Overview and Scope
Self-injection refers to a device used for the act of injecting oneself. Self-injections enable patients and users to administer medicines and drugs that need to be injected into them by themselves without the need for a physician or a medical professional.
Sizing and Forecast
The self-injections market size has grown exponentially in recent years. It will grow from $50.72 billion in 2023 to $63.54 billion in 2024 at a compound annual growth rate (CAGR) of 25.3%. The growth in the historic period can be attributed to rising chronic diseases, improved patient empowerment, regulatory support, preference for home healthcare, cost-effectiveness..
The self-injections market size is expected to see exponential growth in the next few years. It will grow to $147.24 billion in 2028 at a compound annual growth rate (CAGR) of 23.4%. The growth in the forecast period can be attributed to pandemic impact and remote treatment, expansion into emerging markets, patient-centric healthcare, advantages in drug delivery, personalized medicine trends.. Major trends in the forecast period include smart technology integration, rise in biologics usage, miniaturization and wearable devices, enhanced safety features, adoption of autoinjectors..
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/self-injections-global-market-report
Segmentation & Regional Insights
The self-injections market covered in this report is segmented –
1) By Type: Devices, Formulations
2) By Route Of Administration: Skin, Circulatory or Musculoskeletal, Organs, Central Nervous System
3) By Dosage: Single Dose, Multi Dose
4) By Application: Autoimmune Diseases, Hormonal Disorders, Oncology, Orphan Diseases, Pain Management, Respiratory Therapy, Other Applications
5) By Distribution Channel: Hospitals Pharmacies, Clinics, Chemist, Online Pharmacies
North America was the largest region in the self injections market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the self-injections market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8235&type=smp
Major Driver Impacting Market Growth
The growing number of diabetic patients is expected to propel the growth of the self-injections market going forward. Diabetes refers to a condition where the pancreas, a human organ that produces insulin, produce less than an adequate level of insulin which leads to the breakdown of blood sugars and causes serious health conditions like heart disease, vision loss, and kidney diseases. Self-injections can be used by diabetic patients for injecting insulin and other medications which help maintain optimum blood sugar levels and block any excess blood sugars at any given point of time without the help of a medical professional. For instance, according to International Diabetes Federation (IDF), a Belgium-based organization that represents 230 national diabetes associations in more than 160 countries and territories, in 2021, 567 million adults aged between 20 to 79 years are currently living with diabetes, and the number of diabetic patients is expected to grow and reach 643 million by 2030 and 783 million by 2045. Therefore, the growing number of diabetic patients is driving the growth of the self-injections market.
Key Industry Players
Major companies operating in the self-injections market report are AbbVie Inc., Antares Pharma Inc., Baxter International Inc., Bayer AG, Becton Dickinson and Company, Bristol-Myers Squibb Company, Credence MedSystems Inc., Dali Medical Devices Ltd., Eli Lilly and Company, Enable Injections Inc., Gerresheimer AG, Insulet Corporation, Merck & Co. Inc., Owen Mumford Limited, PenJet Corporation, Pfizer Inc., PharmaJet Inc., Recipharm AB, Schott AG, Scintilla Pharmaceuticals Inc., SHL Group.Limited, Terumo Corporation, West Pharmaceutical Services Inc., Wilhelm Haselmeier GmbH & Co. KG, Ypsomed Holding AG, APTAR PHARMA INDIA PVT LTD, Bespak Europe Ltd., Bioject Medical Technologies Inc., Catalent Inc., Crossject SA, Injex Pharma AG, Medeca Pharma AB, Medimop Medical Projects Ltd., Mylan N.V., Nemera Development S.A., Noble Medical Inc.
The self-injections market report table of contents includes:
1. Executive Summary
2. Self-Injections Market Characteristics
3. Self-Injections Market Trends And Strategies
4. Self-Injections Market – Macro Economic Scenario
5. Global Self-Injections Market Size and Growth
…
31. Global Self-Injections Market Competitive Benchmarking
32. Global Self-Injections Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Self-Injections Market
34.Self-Injections Market Future Outlook and Potential Analysis
35. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
